Direkt zum Inhalt
Merck
  • Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells.

Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells.

The American journal of Chinese medicine (2015-02-03)
Byul-Bora Choi, Jeong Hae Choi, Sang-Rye Park, Ji-Young Kim, Jin-Woo Hong, Gyoo-Cheon Kim
ZUSAMMENFASSUNG

Scutellariae radix is one of the most widely used anticancer herbal medicines in several Asian countries, including Korea, Japan, and China. Squamous cell carcinoma (SCC) is one of the most common head and neck carcinomas, which is highly invasive and metastatic, and can potentially develop chemoresistance. Therefore, new effective treatment methods are urgently needed. We determined the effects of Scutellariae radix on SCC-25 cells using the WST-1 assay, F-actin staining, flow cytometry analysis, immunofluorescence staining, and western blot analysis. Scutellariae radix treatment inhibited SCC-25 cell growth in a dose- and time-dependent manner, but it did not inhibit HaCaT (human keratinocyte) cell growth. Changes in cell morphology and disruption of filamentous (F)-actin organization were observed. Scutellariae radix-induced apoptosis as indicated by the translocation of cytochrome c and apoptosis-inducing factor (AIF) into the nucleus and cytosol. Scutellariae radix-induced an increase in cells with sub-G1 DNA content, and increased Bax, cleaved caspase-3, caspase-7, caspase-9, DNA fragmentation factor 45 (DFF 45), and poly(ADP-ribose) polymerase-1 (PARP-1) expression levels. Furthermore, increased expression of phosphorylated mitogen-activated protein kinase (MAPK)-related proteins was detected. The antitumor effect of Scutellariae radix was due to decreased cell proliferation, changes in cell morphology, and the activation of caspase and MAPK pathways. Taken together, the findings of this study highlight the anticancer activity of Scutellariae radix in chemoresistant SCC-25 oral squamous carcinoma cells.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dimethylsulfoxid, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, Molecular Biology
Sigma-Aldrich
Dimethylsulfoxid, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimethylsulfoxid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Dimethylsulfoxid, anhydrous, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Propidiumjodid, ≥94.0% (HPLC)
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥98.5% (GC)
Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
Dimethylsulfoxid, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Phenylmethansulfonylfluorid, ≥99.0% (T)
Sigma-Aldrich
Etoposid, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
Dimethylsulfoxid, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Propidiumjodid -Lösung
Sigma-Aldrich
Dimethylsulfoxid, PCR Reagent
Sigma-Aldrich
Propidiumjodid, ≥94% (HPLC)
Sigma-Aldrich
DL-Glyceraldehyd-3-phosphat -Lösung, 45-55 mg/mL in H2O
Supelco
Dimethylsulfoxid, analytical standard
Supelco
Dimethylsulfoxid, for inorganic trace analysis, ≥99.99995% (metals basis)
USP
Dimethylsulfoxid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dimethylsulfoxid -Lösung, 50 wt. % in H2O
Supelco
5-Fluorouracil, analytical standard
Supelco
Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Fluoruracil, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
Etoposid, European Pharmacopoeia (EP) Reference Standard
Dimethylsulfoxid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
8-Octanoyloxypyren-1,3,6-Trisulfonsäure Trinatriumsalz, suitable for fluorescence, ≥90% (HPCE)